Literature DB >> 10215631

Regulation of opioid receptor activities.

P Y Law1, H H Loh.   

Abstract

From the demonstration of the existence of multiple opioid receptors and the isolation of the endogenous opioid peptides in the brain, it is now clear that the activities of these receptors can be regulated at various levels. The distinct brain regional distribution of the receptor suggests a tight transcriptional regulation. Early findings of alterations in receptor binding associated with tolerance to the opioids implies that the receptor life cycle can be influenced by the presence of agonists. Until the recent reported cloning of opioid receptors, the detailed studies of the molecular mechanisms involved in their regulation could not be conducted. With the availability of the cDNA clones of the mu-, delta- and kappa-opioid receptors, and the elucidation of their gene structures, it is now possible to investigate opioid receptor regulation at various levels, and to identify the specific receptors involved in the pharmacological actions of the opioids. It is now also possible to define the receptor domains responsible for the opioid ligand selectivities, agonist activation, and agonist-induced inactivation. Summarized in this report are our past efforts in defining the regulation of opioid receptor activities. Studies using heterologous expression techniques, mutational analysis of receptors to characterize transcriptional elements, and the in vivo manipulation of the receptor gene levels have made it is possible to determine the mechanisms whereby these receptors are regulated. Our studies have also identified the unique characteristics of opioid receptors as members of the superfamily of G protein-coupled receptors.

Mesh:

Substances:

Year:  1999        PMID: 10215631

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  47 in total

1.  The enigma of morphine tolerance: recent insights.

Authors:  S B Ray; S Wadhwa
Journal:  J Biosci       Date:  2001-12       Impact factor: 1.826

2.  Differentiation of delta, mu, and kappa opioid receptor agonists based on pharmacophore development and computed physicochemical properties.

Authors:  M Filizola; H O Villar; G H Loew
Journal:  J Comput Aided Mol Des       Date:  2001-04       Impact factor: 3.686

3.  Acute withdrawal from chronic escalating-dose binge cocaine administration alters kappa opioid receptor stimulation of [35S] guanosine 5'-O-[gamma-thio]triphosphate acid binding in the rat ventral tegmental area.

Authors:  A P Piras; Y Zhou; S D Schlussman; A Ho; M J Kreek
Journal:  Neuroscience       Date:  2010-05-07       Impact factor: 3.590

Review 4.  Visualizing activation of opioid circuits by internalization of G protein-coupled receptors.

Authors:  Kevin Sinchak; Paul Micevych
Journal:  Mol Neurobiol       Date:  2003-04       Impact factor: 5.590

Review 5.  Opioid receptor regulation.

Authors:  Mark von Zastrow
Journal:  Neuromolecular Med       Date:  2004       Impact factor: 3.843

6.  Protein kinase C-mediated phosphorylation of the μ-opioid receptor and its effects on receptor signaling.

Authors:  Bo Feng; Zhihua Li; Jia Bei Wang
Journal:  Mol Pharmacol       Date:  2011-01-06       Impact factor: 4.436

Review 7.  Homology modeling of opioid receptor-ligand complexes using experimental constraints.

Authors:  Irina D Pogozheva; Magdalena J Przydzial; Henry I Mosberg
Journal:  AAPS J       Date:  2005-10-05       Impact factor: 4.009

Review 8.  Look before leaping: combined opioids may not be the rave.

Authors:  Mellar P Davis; Susan B LeGrand; Ruth Lagman
Journal:  Support Care Cancer       Date:  2005-07-06       Impact factor: 3.603

9.  Investigation on the relationship between cannabinoid CB1 and opioid receptors in gastrointestinal motility in mice.

Authors:  Mauro A M Carai; Giancarlo Colombo; Gian Luigi Gessa; Ratnakumar Yalamanchili; Balapal S Basavarajappa; Balapal S Basavarajppa; Basalingappa L Hungund
Journal:  Br J Pharmacol       Date:  2006-07-17       Impact factor: 8.739

10.  Morphine suppresses intracellular interferon-alpha expression in neuronal cells.

Authors:  Qi Wan; Xu Wang; Yan-Jian Wang; Li Song; Shi-Hong Wang; Wen-Zhe Ho
Journal:  J Neuroimmunol       Date:  2008-06-17       Impact factor: 3.478

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.